Bruker Corporation
Bruker Corporation (BRKR) Revenue
Annual & quarterly revenue history · segment & region breakdown
BRKR · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBruker Corporation trailing twelve-month (TTM) revenue is $3.46B, an increase of 2.08% year-over-year from $3.44B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $3.44B | +$0.07B | +2.08% |
| 2024-12-31 | $3.37B | +$0.40B | +13.56% |
| 2023-12-31 | $2.96B | +$0.43B | +17.14% |
| 2022-12-31 | $2.53B | +$0.11B | +4.67% |
| 2021-12-31 | $2.42B | +$0.43B | +21.66% |
| 2020-12-31 | $1.99B | -$0.09B | -4.11% |
| 2019-12-31 | $2.07B | +$0.18B | +9.34% |
| 2018-12-31 | $1.90B | +$0.13B | +7.34% |
| 2017-12-31 | $1.77B | +$0.15B | +9.59% |
| 2016-12-31 | $1.61B | -$0.01B | -0.77% |
Compare revenue vs peers
Medical - DevicesCompare BRKR revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bruker Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bruker Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bruker Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BRKR revenue · 5 questionsBRKR's trailing twelve-month (TTM) revenue is $3.46B. That is an increase of 2.08% year-over-year from $3.44B in FY2025.
▸ Source: FMP · Bruker Corporation SEC filings · GAAP · Bruker Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026